Noradrenaline improves the tumour to normal blood flow ratio and drug delivery in a model of liver metastases

British Journal of Surgery

Volumn 86, Issue 4, 1999, Pages 453-457

  Shankar, A ^a   Loizidou, M ^a   Burnstock, G ^a   Taylor, I ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ENDOTHELIN; FLUOROURACIL; HYPERTENSIVE FACTOR; N(G) NITROARGININE METHYL ESTER; NORADRENALIN; SODIUM CHLORIDE; VASOPRESSIN;

ANIMAL EXPERIMENT; ARTICLE; BLOOD FLOW; COLORECTAL CANCER; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; HEPATIC ARTERY; INTRAARTERIAL DRUG ADMINISTRATION; ISOTOPE LABELING; LASER DOPPLER FLOWMETRY; LIVER BLOOD FLOW; LIVER METASTASIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR BLOOD FLOW;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; BLOOD FLOW VELOCITY; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; ENZYME INHIBITORS; FLUOROURACIL; LASER-DOPPLER FLOWMETRY; LIVER NEOPLASMS; MALE; NG-NITROARGININE METHYL ESTER; NOREPINEPHRINE; RATS;

EID: 0032911206     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2168.1999.01045.x     Document Type: Article

References (16)

1. 1 Chang AE, Schneider PD, Sugarbaker PH, Simpson C, Culnane M, Steinberg SM. A prospective randomized trial of regional versus systemic continuous S fluorodcoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 1987; 206: 685-93.
2. 2 Martin JK Jr, O'Connell MJ, Wieand HS, Fitzgibbons RJ Jr, Mailliard JA, Rubin J et al. Intra-arterial floxuridine vs. systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial. Arch Surg 1990; 125: 1022-7.
3. 3 Allen-Mersh TG, Earlam S, Fordy C, Abrams K, Houghton J. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. Lancet 1994; 344: 1255-60.
4. 4 Ashraf S, Crowe R, Loizidou M, Turmaine M, Taylor I, Burnstock G. The absence of autonomic perivascular nerves in human colorectal liver metastases. Br J Cancer 1996; 73: 349-59.
5. 5 Hemmingway DM, Angerson WJ, Anderson JH, Goldberg JA, McArdle CS, Cooke TG. Monitoring blood flow to colorectal liver metastases using laser Doppler flowmetry: the effect of angiotensin II. Br J Cancer 1992; 67: 958-60.
6. 6 Loesch A, Turmaine M, Loizidou M, Crowe R, Ashraf S, Taylor I et al. Increase in immunoreactivity for endothelin-1 in blood vessels of rat liver metastases: experimental sarcoma and carcinoma. J Anat 1997; 191: 291-9.
7. 7 Ashrat S, Loizidou M, Crowe R, Turmaine M, Taylor I, Burnstock G. Blood vessels in liver metastases from both sarcoma and carcinoma lack perivascular innervation and smooth muscle cells. Clin Exp Metastasis 1997; 15: 484-98.
8. 8 Hind RE, Loizidou M, Fleming J, Batty V, Birch S, Taylor I. Biodistribution of lipiodol following hepatic arterial injection. Eur J Surg Oncol 1992; 18: 162-7.
9. 9 Krylova NV. Characteristics of microcirculation in experimental tumours. Bibliotheca Anatomica 1969; 10: 301-3.
10. 10 Burton MA, Gray BN. Redistribution of blood flow to experimental hepatic tumours with noradrenaline and propanolol. Br J Cancer 1987; 56: 585-8.
11. 11 Ackerman NB, Jacobs R, Bloom ND, Poon TT. Increased capillary flow in intrahepatic tumors due to alpha-adrenergic effects of catecholamines. Cancer 1988; 61: 1550-4.
12. 12 Goldberg JA, Kerr DJ, Wilmott N, McKillop JH, McArdlle CS. Regional chemotherapy for colorectal metastases; a phase II evaluation of targeted hepatic arterial 5-fluorouracil for colorectal liver metastases. Br J Surg 1990; 77: 1238-40.
13. 13 Dworkin MJ, Carnochan P, Allen-Mersh TG. Nitric oxide inhibition sustains vasopressin-induced vasoconstriction. Br J Cancer 1995; 71: 942-4.
14. 14 Dworkin MJ, Zweit J, Carnochan P, Deehan B, Allen-Mersh TG. Effects of regional angiotensin II infusion on the relationship between tumour blood flow and fluorouracil uptake in a liver metastases animal model. Eur J Cancer 1996; 32A: 1580-4.
15. 15 Dworkin MJ, Carnochan P, Allen-Mersh TG. Effect of continuous regional vasoactive agent infusion on liver metastasis blood flow. Br J Cancer 1997; 76: 1205-10.
16. 16 Jain RK. Barriers to drug delivery in solid tumors. Sci Am 1994; 271: 58-65.